Pular para o conteúdo principal
Ranking Invest

CAPR - Capricor Therapeutics, Inc.

Segmento: HealthcareCapricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.

Análise Ranking Invest

Valor de Mercado
$ 362.21 Mi
IVR
0.02Índice proprietário de comparação relativa: 0,02.
IVR2
-0.67Leitura proprietária complementar: -67%.
MLL
-0.67Leitura proprietária complementar: -67%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 246.22 Mi

Dívida Líquida

-$ 20.94 Mi

L4T

-$ 129.42 Mi

Indicadores Básicos

ROE

-52.56%

Índices de Previsibilidade

Receita Líquida

G0.91

Lucro

E1.27

Margem

D0.81

Índices de Tendência

Receita Líquida

E-4.16

Lucro

G-10.46

Margem

B7.75

Índices de Endividamento

DIV/PAT

-0.09

DIV/L4T

0.16

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.